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Sl l l l~mal~ 
Target cell expression of major histocompatibility complex (MHC) class I molecules correlates 
with resistance to lysis by natural killer (NK) cells. Prior functional studies of the murine NK 
cell surface molecule, Ly-49, suggested its role in downregulating NK cell cytotoxicity by specifically 
interacting with target cell H-2D d molecules. In support of this hypothesis, we now demonstrate 
a physical interaction between H-2D d and Ly-49 in both qualitative and quantitative cell-cell 
binding assays employing astable transfected Chinese hamster ovary (CHO) cell line expressing 
Ly-49 and MHC class I transfected target cells. Binding occurred only when CHO cells expressed 
Ly-49 at high levels and targets expressed H-2D d by transfection. Monodonal antibody blocking 
experiments confirmed this interaction. These studies indicate that the specifidty of natural killing 
is influenced by NK cell receptors that engage target cell MHC class I molecules. 
N rK cells spontaneously lyse certain transformed orvirally infected cells but do not kill normal cells (1, 2). Al- 
though the molecular basis for NK cell specificity is poorly 
understood, target cell susceptibility o spontaneous cytotox- 
icity is inversely proportional to their level of expression of 
certain MHC class I molecules (3-5). Two explanations (6) 
have been proposed. MHC class I molecules may "mask" or 
interfere with recognition of putative target cell ligands by 
activation receptors on NK cells. Alternatively, target cell 
MHC class I molecules may directly engage NK cell receptors 
leading to inhibitory events in NK ceils. Our previous func- 
tional studies (7) of the murine Ly-49 molecule have sup- 
ported the latter hypothesis. 
Ly-49 is a type II integral membrane protein (8, 9), with 
an external C-type lectin domain (9), expressed on a distinct 
subset of murine NK cells (10) as a disulfide-linked homodimer 
of44-kD subunits (9). Functional studies with IL-2-activated 
NK cells demonstrated that Ly-49 + NK cells generally 
manifested a lytic capacity equivalent to Ly-49- NK cells 
(7). However, Ly-49 + NK cells were unable to lyse targets 
of H-2 k or H-2 d haplotype despite efficient lysis of these 
targets by Ly-49- NK cells, demonstrating that Ly-49 ex- 
pression significantly influences NK cell target specificity. 
Transfection of a susceptible target cell line with cDNA en- 
coding H-2D a rendered it resistant o lysis by Ly-49 + NK 
cells. Ly-49 + NK cells were unable to lyse the D a transfec- 
tant by other stimuli, including Ab-dependent cellular cyto- 
toxicity (7, 11). Gene transferred resistance was abrogated 
by mAbs against either Ly-49 or the otl/o~2 domain of D a. 
These data were compatible with our hypothesis that Ly-49 
is an inhibitory receptor that specifically recognizes Da mol- 
ecules on targets. 
Our interpretation f t.hese functional studies predicts that 
Ly-49 directly interacts with H-2D d. Alternatively, the 
results may be explained by a NK cell surface molecule that 
is coexpressed with Ly-49 and that is indirectly influenced 
by the anti-Ly-49 mAb. Moreover, reversal of functional 
inhibition by mAbs could be due to other effects such as 
direct anti-Ly-49 triggering or anti-H-2D d dissociation of 
another effector cell ligand (12). A final possibility involves 
the "masking model" in which H-2D a masks another target 
molecule specifically recognized by Ly-49 (13). To distinguish 
between these possibilities, we sought to unequivocally es- 
tablish the ligand for Ly-49. We have now overexpressed Ly-49 
on Chinese hamster ovary (CHO) cells by transfection and 
DNA amplification. CHO cells bind target cells only when 
the cells express high levels of Ly-49 and H-2D a, respec- 
tively, by transfection. This interaction is specifically blocked 
by appropriate mAbs. Thus, this study demonstrates that Ly-49 
is a receptor for a MHC class I molecule, further substan- 
tiating a role for target cell MHC class I molecules in innate 
immunity in addition to acquired (T cell-mediated) immunity. 
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Materials and Methods 
Cell Culture. All cell lines were maintained in RPMI 1640 (Me- 
diatech Inc., Washington, D.C.) supplemented with 10% FCS (Hy- 
clone Labs., Logan, UT) 100 U/m1 penicillin K, 0.1 ms/m1 strep- 
tomycin sulphate, and 0.3 mg/ml t-glutamine (GIBCO BRL, 
Gaithersburg, MD). CHO cells, deficient in the dihydrofolate r duc- 
tase gene (dhfr-), were grown in Ham F-12 media with the above 
supplements. The C1498 transfectants, expressing Dd, K a, or L d, 
were described previously (7) and were maintained in media con- 
taining 0.5 mg/ml G418 (GIBCO BILL). 
mAbs. The mAbs A1 (anti-Ly-49) and PK136 (anti-NKl.1) have 
been previously described (14, 15). The anti-MHC mAbs were 34- 
5-8S (anti-c~l/cx2 domains of D a, 34-2-12 (anti-oe3 domain of Da), 
and B22.249 (anti-D b) (16, 17). All anti-MHC mAbs bind to 
C1498-D dtarget cells at the same density by flow cytometry (data 
not shown). 
Production and Amplification of Ly-49 + ClIO Cells. The HindlII 
fragment of pal.3 (9) was subcloned into the HindlII site of 
pH/~APr-1 neo (18). Constructs containing the Ly-49 cDNA in 
the sense and inverse (Inv) orientation with respect to the promoter 
were identified and done& The EcoRI-PvuII fragment of pSV2- 
dhfr (19) containing the dhfr cDNA was subeloned into the Eco 
ILl site of both Ly-49 expression constructs. The resulting plasmids 
contained the Ly-49 cDNA (in either the sense or inverted orienta- 
tions) under the control of the human ~-actin promoter and the 
dhfr cDNA under the control of the SV40 early promoter. The 
plasmids were linearized by EcoRI digestion and individually elec- 
troporated (Gene Pulser; Bio-Rad Laboratories, Hercules, CA) into 
dhfr- CHO cells. Resistant ceils were initially selected and cloned 
in 1.5 mg/ml G418. Clones were then transferred toc~-MEM media 
(ICN/Flow, Costa Mesa, CA) with 10% dialyzed FCS. Cells trans- 
fected with the Ly-49 sense construct, that grew in both selection 
medias and expressed Ly-49 on their surface by FACS | analysis 
(Becton Dickinson & Co., Mountain View, CA), were subjected 
to three rounds of amplification with successively higher concen- 
trations of methotrexate (MTX; Sigma Chemical Co., St. Louis, 
MO) and maintained at 1.28 /~M MTX to establish Ly-49 High 
CHO cells. In parallel cultures, CHO cells transfected with the 
inverse oriented construct were subjected to the same selection and 
three rounds of MTX amplification but clones were randomly 
picked. The Ly-49 ~nV CHO cells were also maintained in 1.28/~M 
MTX. Ly-49 g~ CHO cells were isolated from cells transfected 
with the sense construct after a single cycle of MTX amplification 
and were maintained in 20 nM MTX. 
Rosette Assay. Ly-49His h CHO or Ly-49~n~CHO cells (3 x 104) 
were grown overnight in 24-well tissue culture plates and washed 
twice with wash buffer (HBSS with 3% FCS). The targets were 
washed twice with cold wash buffer and diluted to 6 x 105 
cells/ml; 500k aliquots were added to each well and incubated for 
45 min in a 37~ 5% CO2 incubator. Wells were washed twice 
with wash buffer and photographed with a phase contrast inverted 
microscope. 
Quantitative Binding Assay. This assay uses centrifugation of 
inverted 96-well plates to remove unbound labded target cells 
from CHO cell monolayers, permitting reproducibility and objec- 
tivity (modified from 20). In this assay, CHO cells (6 x 103) 
were grown overnight in a 96-welI tissue culture plate. Target 
cells were washed twice with ILPMI 1640 (without FCS). The 
fluorescent dye, BCECF-AM (2',7'-bis-[2-carboxyethyl]-5-[and-6]- 
carboxyfluorescein, acetoxymethyl ester; Molecular Probes, Inc., 
Eugene, OIL), was solubilized in DMSO and diluted to 50/zg/ml 
in RPMI 1640. The target cells (4 x 106) were resuspended in 
1 ml of diluted BCECF-AM and incubated for 2 h in a 37~ 5% 
CO2 incubator. Target cells were then washed twice with cold 
wash buffer and diluted to 1.6 x 10 ~ cells/ml. 50k aliquots were 
added to washed CHO cell monolayers and returned to the CO2 
incubator for 45 min. Wells were filled to a bulging meniscus with 
wash buffer, sealed with waterproof tape, inverted, and centrifuged 
in the upside down position at 300 g for 4 min. While still in- 
verted, the sealant ape was removed, the plate drained, blotted, 
and reverted to the upright orientation. The remaining cells were 
lysed with 100X of lysis buffer (25 mM Tris, 0.1% SDS). 100X 
aliquots from each well were transferred into a disposable cuvette 
filled with 4 ml of lysis buffer. Relative fluorescence (RF) (com- 
pared to buffer alone) was determined with a spectrofluorimeter 
(Fluorolog 2; Spex, Inc., Edison, NJ) at 502 nM excitation and 
530 nM emission. Percent specific binding was calculated with the 
following formula: (RF~ple - RFafi-c,o)/(RF~ - RFa~-cHo). 
RFs~mplc is the RF of the experimental sample whereas ILFaf,-cao 
is the background fluorescence remaining in wells with untrans- 
fected dhfr- CHO cells (always <8% of RFm~) and RFm~ is the 
total fluorescence added to each well as measured by fluorescence 
of unwashed wells with labeled targets and dhfr- CHO cells. The 
mean of duplicate wells for each point was used in the calcula- 
tion. In experiments hat used mAbs, saturating concentrations 
(1:200-1:500) of ascites preparations were added to target cells or 
to CHO cell monolayers 30 min before the assay. 
FACS | Analysis. A FACScan | with the Consort 32 software 
program (Becton Dickinson & Co.) was used to analyze CHO cells 
for Ly-49 expression with mAb A1 (anti-Ly-49) as described previ- 
ously (7). 
_j- 
Log F luorescence 
Figure I. Expression of Ly-49 on CHO cells. Ly-49Hig h (histogram I), 
Ly-49 g~ (2), Ly-49 lnv (3), and parental dhfi-deficient CHO cells (4) were 
indirectly stained with anti-Ly-49 mAb and FITC-conjugated goat 
anti-mouse Is, and analyzed by flow cytometry as described (7). Back- 
ground staining of Ly-49his h and Ly-49 L~ cells (either unstained or with 
second-step reagent alone, data not shown) overlap histograms 3 and 4. 
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Results 
Ly-49~i~ h ClIO Cells Rosette H-21~ Targets. To determine 
a specific physical interaction between Ly-49 and H-2D d, our 
experimental approach employed binding assays between trans- 
fected cells expressing high levels of Ly-49 and transfected 
target cells expressing various MHC class I molecules. Similar 
systems uccessfully established the physical interaction be- 
tween CD4 and CD8 and their respective MHC ligands (21, 
22). The dhfr- CHO cells were transfected with an expres- 
sion plasmid containing the Ly-49 cDNA and dhfr. Ly-49 
expression was amplifed by exposing positive clones to suc- 
cessively higher concentrations of MTX. Two cell lines, Ly- 
49 l-Iigh and Ly-49 r~ CHO cells were developed. By flow 
cytometry, Ly-49rtig h CHO cells expressed Ly-49 at 30-40 
times the level on Ly-49 r~ CHO cells (Fig. 1) which in 
turn was comparable to Ly-49 + NK cells constitutively ex- 
pressing Ly-49 (data notshown). Immunoprecipitation analysis 
with mAb A1 (anti-Ly-49) showed that Ly-49 was appropri- 
ately expressed on Ly-49 + CHO cells as a disulfide-linked 
homodimer with the expected molecular mass (data not 
shown). In parallel cultures, a control cell line, Ly-49 I~v 
CHO, was produced by transfection with a plasmid containing 
an inverted Ly-49 cDNA and subjected to the same three 
rounds of MTX amplification as Ly-49uig h CHO cells. Pa- 
rental and Ly-49 I~v CHO cells did not express Ly-49 (Fig. 1).
Ly-49His h CHO cells were qualitatively able to rosette 
transfected cells expressing H-2D d (C1498-Da), whereas un- 
transfected C1498 and C1498-K a cells did not bind (Fig. 2). 
Binding of C1498-D d cells was specific for Ly-49Hig h CHO 
cells because they did not bind Ly-49 Inv CHO cells. Thus, 
rosette formation between these transfected cells appeared to 
be dependent on a specific interaction between Ly-49 and 
H-2D d. 
LF49 Specifically Recognizes H-2D a. To eliminate any sub- 
jective bias in our rosette analysis, a quantitative assay was 
developed in which the only detectable binding was between 
Ly-49 r~igh CHO cells and C1498-D d cells (Fig. 3 A). Un- 
transfected C1498, C1498-K a, and C1498-L d id not adhere 
to Ly-49~ig h CHO cells. The Ly-49 I"v CHO cells did not 
bind any targets. A high level of Ly-49 expression was re- 
quired for binding because C1498-D d cells did not adhere 
to Ly-49 r~ CHO cells (Fig. 3 B). Thus, in rosette and quan- 
titative assays, adhesion between transfected CHO and C1498 
cells demonstrated aninteraction between Ly-49 and H-2D d. 
The specificity of this interaction was further confirmed 
by mAb blocking studies. Preincubation of Ly-49Hig h 
CHO cells with mAb A1 (anti-Ly-49) prevented binding to 
C1498-D d cells, whereas an isotype control mAb had no 
effect (Fig. 4). Incubation of C1498-D a cells with a mAb 
specific for otl/ot2 domains of D d also blocked binding. 
mAbs directed against D b or the or3 domain of D d had no 
effect despite quivalent binding of all mAbs to C1498-D a
cells by FACS | analysis (data not shown). Similar analysis 
with the rosette assay confirmed these results (data not shown). 
Discussion 
In this report, we describe a physical interaction between 
Ly-49 and H-2D d in binding assays in which target cells 
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Figure 2. Ly-49Hig b CHO cells 
rosette H-2Dd-expressing target 
cells. Parental C1498 (a and d) or 
C1498 ~ transfected with cDNAs 
encoding D d (b and e) or K d (c and 
J) were assayed for ability to rosette 
with Ly-498i8 h (a-c) or Ly-491nv 
CHO cells (d-j). The CHO ~ls  ap- 
pear as large polygonal cells whereas 
target cells are small, round, and 
refractile, x50. 
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Figure 3. Quantitative binding of target cells e~pressing H-2D d to Ly- 
49Hig h CHO cells. (A) Ly-49Hig h, or Ly-491" CHO cells were tested for 
ability to bind parental CI498 target cells, or C1498 cells transfected with 
cDNAs encoding H-2D a, K a, or L a in a quantitative fluorescence binding 
assay. (B) Binding depends on level of Ly-49 expression on CHO cells. 
Ly-49Hig h, Ly-49 I-~ and Ly-49 Inv CHO cells were assayed for binding pa- 
rental C1498 cells or C1498-D a cells. 
adhere to Cl iO cells only when the target expresse(t H-2D a 
and the CHO cell expresses Ly-49 at high levels. The specificity 
of this interaction was therefore established in a system in 
which adherent cells differed from nonadherent cells only by 
transfection and expression of the relevant cDNAs, mAb 
blocking experiments confirmed this specificity. Thus, Ly-49 
specifically engages H-2D a molecules. 
While this manuscript was being prepared, complemen- 
tary results were reported by Kane (23) who showed that 
Ant i -NK  1 .1  
Ant i -D  d (x I / (x2  
Ant i -D  d a3 
Ant i -D  b 
Ant1-Ly-49 
<x" /  " z z ' 
[ , u'" 
0 I 0 20 30 
% Specific Binding 
I 
40 
Figure 4. mAbs specific for Ly-49 or (xl/(x2 domains ofH-2D a block 
binding. Quantitative binding between Ly-49H~ CHO cells and C1498-D a 
cells was assayed in the absence or presence of the indicated mAbs. Ly- 
49 I"v CHO cells failed to bind target cells (Fig. 3 and data not shown). 
the ability of tumor cells, such as EL-4, to bind immobilized 
immunopurified H-2D d could be correlated with Ly-49 ex- 
pression. Binding of EL-4 was also detected to H-2K b and 
H-2D k. Previous NK cell functional results predicted that 
Ly-49 should bind to H-2D a and an H-2LMHC class I 
product, consistent with H-2D k, as reported (7, 23). How- 
ever, Ly-49 belongs to a family of highly related molecules 
(24, 25) encoded by crosshybridizing transcripts of similar 
size. It thus remained possible that EL-4 cells could express 
these related molecules, each binding different MHC class 
I molecules. Although anti-Ly-49 mAb specifically blocked 
EL-4 binding to immunopurified H-2D d and H-2D k, the 
mAb could recognize Ly-49-related molecules. Another pos- 
sible interpretation of the EL-4 experiments i that the mAb 
could sterically hinder binding of an unrelated molecule, coex- 
pressed and physically associated with Ly-49, that actually 
mediates binding to MHC dass I molecules. Our results 
eliminate these possible alternative interpretations because 
binding only occurred when paired cell lines express Ly-49 
and H-2D a, respectively, by transfection. 
Our current results also differ from the EL-4 binding studies 
in the anti-H-2D d mAb blocking experiments and in 
binding to H-2K b (23). In EL-4 binding, the H-2Da-(x3 do- 
main appeared to be nearly as important as the o(1/o(2 do- 
main. In contrast, functional studies demonstrated that the 
same anti-H-2Da-ot3 domain mAb had no effect, suggesting 
that the (x3 domain is not involved (7). Other studies (26, 
27) have also demonstrated that specific amino acids in the 
or1 helix can regulate MHC dass I-associated target cell sus- 
ceptibility to NK cells. A single substitution in HLA-A2 
(His-74 to Asp-74) converted anonprotective phenotype into 
one that was protective (26). A possible explanation for this 
discrepancy is that other cell surface molecules on EL-4 cells 
may contribute to its binding to immunopurified MHC class 
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I molecules. Similarly, EL-4 binding to H-2K b differed from 
its binding to H-2D d and H-2D k because the anti-Ly-49 
mAb did not block binding of EL-4 to H-2K b (23). Indeed, 
there was no prior evidence suggesting that H-2K b, ex- 
pressed by several sensitive targets, had any effect on cytotox- 
icity by Ly-49 + effector cells (7). Moreover, in our current 
experiments, the various C1498 targets express H-2K b nor- 
mally and at the same levels (7) but do not bind Ly-49 High 
CHO cells. Thus, binding of Ly-49 + EL-4 cells to H-2K b 
is not due to Ly-49 and may be due to other molecules ex- 
pressed by EL-4. 
Our current results suggest hat binding of Ly-49 to 
H-2D d primarily involves the peptide binding domains of 
MHC class I molecules in a manner similar to interaction 
of MHC class I-restricted TCRs rather than CD8 molecules 
(28, 29). The possible binding of Ly-49 to the H-2D a- 
otl/ot2 domain suggests that bound peptides may alter MHC 
class I-associated protection by influencing interaction with 
NK cell receptors. The ability to assay a physical interaction 
between Ly-49 and MHC class I molecules hould permit 
exploration of this hypothesis and determination of the 
significance of the C-type lectin homology of Ly-49 (9). 
The current results clearly suggest that, in natural killing, 
MHC class I-associated target cell resistance may be attrib- 
uted to specific recognition of target cell MHC class I mole- 
cules by NK cell receptors uch as Ly-49. When considered 
together with previous functional studies with Ly-49 § 
effector cells, the physiologic role of physical interaction be- 
tween Ly-49 and H-2D d is probably not cell adhesion per 
se even though we have used cell adhesion to demonstrate 
this interaction. The quantitative assay demonstrated that a 
lower level of Ly-49 expression, comparable to constitutive 
expression on Ly-49 + NK cells was insufficient o produce 
detectable c ll adhesion. This suggests that the binding affinity 
may be relatively low, i.e., TCR-MHC interaction (30), or 
alternatively, Ly-49 could bind with high affinity to only a 
subset of H-2D a molecules, perhaps those displaying specific 
peptides. Although further studies are necessary to delineate 
the precise mechanism by which D ~ engagement of Ly-49 
subsequently influences NK cell cytotoxicity, we favor the 
hypothesis that physical engagement of Ly-49 subsequently 
triggers an inhibitory signal that overrides NK cell activa- 
tion (6, 7, 11). This interpretation also suggests that an NK 
cell possesses another eceptor esponsible for NK cell acti- 
vation in natural killing. Therefore, the susceptibility of a 
target o a particular NK cell may be determined by target 
expression of specific MHC class I molecules and a putative 
ligand for the activation receptor, as well as expression of 
the appropriate specific NK cell receptors. 
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